PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $223,000 | -60.7% | 4,185 | -57.0% | 0.00% | -75.0% |
| Q2 2022 | $567,000 | -38.3% | 9,722 | -19.2% | 0.00% | -33.3% |
| Q1 2022 | $919,000 | +500.7% | 12,035 | +374.6% | 0.01% | +500.0% |
| Q4 2021 | $153,000 | +12.5% | 2,536 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $136,000 | -28.4% | 2,437 | -22.0% | 0.00% | -50.0% |
| Q2 2021 | $190,000 | -65.8% | 3,124 | -60.6% | 0.00% | -66.7% |
| Q1 2021 | $555,000 | +115.1% | 7,925 | +84.1% | 0.01% | +100.0% |
| Q4 2020 | $258,000 | +9.3% | 4,305 | +9.3% | 0.00% | -25.0% |
| Q3 2020 | $236,000 | +26.9% | 3,938 | +12.3% | 0.00% | +33.3% |
| Q2 2020 | $186,000 | +102.2% | 3,507 | +22.6% | 0.00% | +50.0% |
| Q1 2020 | $92,000 | – | 2,860 | +18966.7% | 0.00% | – |
| Q1 2018 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |